https://ctrials.licorn-servier.dev/trial/long-term-safety-study-of-abexinostat-s-078454-per-os-given-as-single-agent-in-haematological-malignancies-extension-study/ 2017-10-11T10:04:06+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-effect-of-agomelatine-and-escitalopram-on-emotions-and-motivation-in-healthy-male-and-female-volunteers/ 2017-10-11T10:04:12+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-dose-escalation-study-of-oral-administration-of-met-tyrosine-kinase-inhibitor-s-49076-in-patients-with-advanced-solid-tumours/ 2017-10-11T10:04:17+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-ii-study-of-oral-administration-of-s-49076-given-in-combination-with-gefitinib-in-patients-with-egfr-mutated-advanced-non-small-cell-lung-cancer-who-have-progressed-after-treatment-with-egfr-t/ 2017-10-11T10:04:28+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-dose-escalation-study-of-oral-administration-of-pan-histone-deacetylase-hdac-inhibitor-s-78454-in-patients-with-solid-tumour/ 2017-10-11T10:05:00+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-dose-escalation-study-of-oral-administration-of-s-78454-given-with-a-fixed-dose-infusion-of-doxorubicin-administered-weekly-3-out-of-4-weeks-in-patients-with-solid-tumour/ 2017-10-11T10:05:05+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-dose-escalation-study-of-s-78454-hdaci-p-o-in-combination-with-folfox-in-patients-with-locally-advanced-or-metastatic-digestive-cancer/ 2017-10-11T10:05:08+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-dose-escalation-study-of-oral-administration-of-the-histone-deacetylase-hdac-inhibitor-s-78454-given-in-combination-with-a-fixed-dose-infusion-of-cisplatin-in-patients-with-advanced-solid-tu/ 2017-10-11T10:05:12+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-dose-escalation-study-of-oral-administration-of-pan-histone-deacetylase-hdac-inhibitor-s-78454-given-in-combination-with-a-fixed-dose-infusion-of-cisplatin-in-patients-with-advanced-non-kera/ 2017-10-11T10:05:17+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-dose-escalation-study-of-s-81694-administered-intravenously-in-adult-patients-with-advanced-metastatic-solid-tumors/ 2017-10-11T10:05:31+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-micronised-purified-flavonoic-fraction-on-microcirculation-in-women-suffering-from-chronic-venous-disease/ 2017-10-11T10:05:40+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/impact-of-daflon-500-mg-on-the-progression-of-chronic-venous-disease-and-symptoms-in-patients-operated-on-for-varicose-veins-with-conservation-of-the-great-saphenous-vein-a-multicentre-double-blind/ 2017-10-11T10:05:45+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-assessment-of-two-schemes-of-oral-administration-of-once-daily-extended-release-metformin-metformin-xr-in-type-2-diabetic-patients-previously-treated-with-metformin-in-combinatio/ 2017-10-11T10:05:50+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-the-fixed-oral-low-dose-perindopril-arginine-3-5-mg-amlodipine-2-5-mg-combination-compared-with-each-component-perindopril-arginine-3-5-mg-and-amlodipine-2-5-mg-and-with-perin/ 2017-10-11T10:05:55+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-randomized-double-blind-placebo-controlled-parallel-international-multicenter-study-assessing-the-efficacy-of-s066913-in-patients-with-paroxysmal-atrial-fibrillation-double-blind-international/ 2017-10-11T10:06:01+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/assessment-of-the-effects-on-24-hour-ambulatory-blood-pressure-and-the-safety-of-a-once-a-day-oral-8-mg-perindopril-morning-administration-versus-evening-administration-in-hypertensive-patients-an-8/ 2017-10-11T10:06:08+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-double-blind-multicenter-international-randomised-study-to-assess-the-effects-of-4-month-oral-administration-of-2g-per-day-of-strontium-ranelate-versus-placebo-on-the-bone-quality-and-remodelling/ 2017-10-11T10:06:15+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-effects-on-heart-rate-haemodynamic-parameters-safety-and-tolerability-of-5-mg-bolus-of-ivabradine-followed-by-8-hour-infusion-at-the-dose-of-5-mg-of-ivabradine-given-after-a-percut/ 2017-10-11T10:06:31+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-effects-of-3-successive-oral-dosages-2-5-5-7-5-mg-b-i-d-of-ivabradine-in-patients-with-stable-moderate-to-severe-systolic-chronic-heart-failure-treated-with-beta-blockers-a-9-w/ 2017-10-11T10:06:37+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-effects-of-oral-administration-of-ivabradine-5-mg-and-7-5-mg-b-i-d-in-patients-with-heart-failure-and-arterial-hypertension-insufficiently-controlled-by-oral-perindopril-4-mg-per-da/ 2017-10-11T10:06:43+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-ivabradine-iv-versus-placebo-on-haemodynamic-parameters-in-patients-with-a-low-cardiac-output-syndrome-following-planned-coronary-artery-bypass-surgery-and-requiring-positive-inotropic-trea/ 2017-10-11T10:06:48+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/determination-of-the-efficacious-and-safe-dose-of-ivabradine-in-paediatric-patients-with-dilated-cardiomyopathy-and-symptomatic-chronic-heart-failure-aged-from-6-months-to-less-than-18-years-a-random/ 2017-10-11T10:06:53+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-oral-administration-of-ivabradine-7-5-mg-bid-on-post-ischaemic-stunning-induced-by-exercise-stress-in-patients-with-coronary-artery-disease-and-exercise-inducible-ischaemia/ 2017-10-11T10:06:59+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-oral-chronic-administration-of-ivabradine-7-5-mg-bid-in-comparison-to-placebo-bid-on-top-of-beta-blockers-on-central-aortic-blood-pressure-randomized-cross-over-double-blind-multic/ 2017-10-11T10:07:03+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-ivabradine-on-vascular-function-in-individuals-at-increased-risk-of-developing-cardiovascular-disease-and-with-impaired-endothelial-function-an-international-multicentre-randomised-doubl/ 2017-10-11T10:07:07+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effect-of-ivabradine-versus-placebo-on-cardiac-function-exercise-capacity-and-neuroendocrine-activation-in-patients-with-chronic-heart-failure-with-preserved-left-ventricular-ejection-fraction-an-8/ 2017-10-11T10:07:12+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-terutroban-versus-aspirin-on-composition-of-atherosclerotic-plaque-in-patients-undergoing-a-carotid-endarterectomy-a-multicentre-randomised-double-blind-two-parallel-group-study-compari/ 2017-10-11T10:07:16+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-s-18886-on-platelet-function-in-type-2-diabetic-patients-treated-by-low-dose-aspirin-and-with-elevated-levels-of-thromboxane-a2-a-multicentre-randomised-double-blind-cross-over-study-co/ 2017-10-11T10:07:21+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-25-mg-with-potential-adjustment-at-50-mg-given-orally-once-a-day-for-12-weeks-in-out-patients-with-generalised-anxiety-disorder-a-randomised-flexible-dose-double/ 2017-10-11T10:07:33+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effect-of-agomelatine-25-mg-given-orally-once-a-day-for-7-days-on-cerebral-activity-measured-by-functional-mri-during-processing-of-emotional-stimuli-in-patients-with-major-depressive-disorder-a-ra/ 2017-10-11T10:07:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/pharmacokinetics-and-safety-of-agomelatine-in-children-from-7-to-less-than-12-years-and-adolescents-from-12-to-less-than-18-years-with-depressive-or-anxiety-disorder-an-open-labelled-multicenter/ 2017-10-11T10:07:49+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/safety-and-efficacy-of-s-33138-versus-risperidone-in-schizophrenic-patients-with-predominant-positive-symptoms-a-pilot-phase-iia-international-multicentre-randomised-double-blind-parallel-group/ 2017-10-11T10:07:53+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-randomised-double-blind-placebo-and-olanzapine-controlled-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-3-fixed-doses-of-s-33138-in-treatment-of-patients-with-an-acute-episode-of/ 2017-10-11T10:07:58+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/exploratory-study-of-s-38093-versus-placebo-in-patients-with-mild-to-moderate-alzheimers-disease-an-international-multi-centre-randomised-double-blind-placebo-controlled-phase-iia-study/ 2017-10-11T10:08:03+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/safety-and-efficacy-of-s-38093-and-donepezil-during-4-weeks-in-patients-with-mild-to-moderate-alzheimers-disease-an-international-multi-centre-randomised-double-blind-placebo-controlled/ 2017-10-11T10:08:08+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-3-doses-of-s-38093-2-5-and-20-mg-day-versus-placebo-in-patients-with-mild-to-moderate-alzheimers-disease-a-24-week-international-multi-centre-randomised-double/ 2017-10-11T10:08:13+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-3-doses-of-s-38093-2-5-and-20-mg-day-versus-placebo-in-co-administration-with-donepezil-10-mg-day-in-patients-with-moderate-alzheimers-disease-a-24-week-internat/ 2017-10-11T10:08:20+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-pharmacodynamics-pharmacokinetics-and-safety-of-repeated-escalating-oral-doses-of-s-38844-versus-placebo-in-patients-with-chronic-heart-failure-and-left-ventricular-systolic-dysfunc/ 2017-10-11T10:08:28+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-effects-of-4-oral-dosages-of-s-44121-versus-placebo-on-cardiac-function-and-nt-probnp-in-patients-with-chronic-heart-failure-and-left-ventricular-dysfunction-a-12-week-randomized/ 2017-10-11T10:08:33+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-effects-of-4-oral-dosages-of-s-44121-versus-placebo-on-cardiac-function-and-nt-probnp-in-patients-with-chronic-heart-failure-and-left-ventricular-dysfunction-not-treated-with-a-beta/ 2017-10-11T10:08:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-three-oral-dosages-of-s-44121-on-cardiac-arrhythmia-during-exercise-testing-in-patients-with-catecholaminergic-polymorphic-ventricular-tachycardia-type-1-a-3-day-single-blind-internation/ 2017-10-11T10:08:43+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-anti-arrhythmic-effects-of-3-oral-dosages-of-s-44121-versus-placebo-in-patients-with-chronic-heart-failure-and-left-ventricular-systolic-dysfunction-at-risk-for-ventricular-arrhythmi/ 2017-10-11T10:08:48+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-acute-and-chronic-oral-administration-of-s-44121-versus-placebo-on-cardiac-arrhythmia-during-exercise-testing-in-patients-with-catecholaminergic-polymorphic-ventricular-tachycardia-type-1/ 2017-10-11T10:08:52+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/dose-ranging-study-of-s-44497-administered-orally-once-daily-for-four-weeks-in-type-2-diabetic-patients-a-multicentre-randomised-double-blind-double-dummy-phase-ii-study-versus-placebo-and-glimep/ 2017-10-11T10:08:57+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/an-open-label-safety-and-pharmacokinetic-study-of-gevokizumab-in-subjects-with-behcets-disease-uveitis/ 2017-10-11T10:09:18+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-subcutaneous-administration-of-30-mg-of-s-78989-versus-placebo-and-evaluation-of-the-subcutaneous-administration-of-60-mg-of-s-78989-versus-placebo-on-the-reduction-of-arterial-wall/ 2017-10-11T10:09:22+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-randomised-double-blind-placebo-controlled-proof-of-concept-study-of-the-efficacy-of-gevokizumab-60mg-subcutaneously-every-4-weeks-over-24-weeks-in-the-treatment-of-patients-with-polymyositis-der/ 2017-10-11T10:09:27+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/dose-response-study-of-gevokizumab-s78989-3mg-10mg-30mg-or-60mg-in-patients-with-type-2-diabetes-and-diabetic-kidney-disease-dkd-a-66-week-international-multicenter-randomized-double-blind/ 2017-10-11T10:09:32+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-randomised-double-blind-placebo-controlled-proof-of-concept-study-of-the-efficacy-and-safety-of-gevokizumab-in-the-treatment-of-patients-with-giant-cell-arteritis/ 2017-10-11T10:09:37+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/an-exploratory-open-label-single-centre-phase-ii-proof-of-concept-study-of-gevokizumab-treatment-in-patients-with-schnitzler-syndrome/ 2017-10-11T10:09:42+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-2-doses-of-s-90098-1-and-2mg-day-sublingual-formulation-for-8-weeks-in-out-patients-with-major-depressive-disorder-an-8-week-randomised-double-blind-fixed-dose-internatio/ 2017-10-11T10:09:51+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-3-doses-0-25-0-5-and-1mg-day-of-agomelatine-sublingual-administration-over-an-8-week-treatment-period-in-out-patients-with-major-depressive-disorder-an-8-week-randomised/ 2017-10-11T10:09:57+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/assessment-of-blood-glucose-profile-in-type-2-diabetic-patients-after-a-one-week-treatment-with-gliclazide-60-mg-mr-using-both-the-glycaemic-holter-method-and-multiple-blood-glucose-samples-a-double/ 2017-10-11T10:10:22+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effect-of-memantine-20-mg-ebixa-and-donepezil-5-mg-aricept-on-motor-cortex-plasticity-induced-by-paired-associative-stimulation-using-transcranial-magnetic-stimulation-tms-in-patients-suffering/ 2017-10-11T10:10:27+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/assessment-of-active-thrombin-activatable-fibrinolysis-inhibitor-tafia-plasma-kinetics-in-patients-at-acute-stage-of-ischemic-stroke-prospective-multicentre-open-non-randomised-biomarker-study/ 2017-10-11T10:10:32+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-one-year-multicentre-international-randomised-double-blind-study-with-comparison-of-benfluorex-150-mg-od-to-150-mg-tid-versus-pioglitazone-30-mg-od-to-45-mg-od-in-combination-with-sulfonylure/ 2017-10-11T10:10:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/international-follow-up-study-after-the-investigational-drug-exposure-in-diabetic-patients-previously-included-in-the-regulate-trial-benfluorex-versus-pioglitazone/ 2017-10-11T10:10:43+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-tianeptine-oral-administration-25-to-50-mg-day-in-elderly-patients-suffering-from-major-depressive-disorder-a-8-week-randomized-double-blind-flexible-dose-parallel-groups/ 2017-10-11T10:10:47+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/early-treatment-of-idiopathic-parkinsons-disease-ipd-with-dopaminergic-agonist-piribedil-in-monotherapy-adaptation-of-the-daily-dose-from-150-to-300-mg-per-day-per-os-a-2-year-randomised/ 2017-10-11T10:10:52+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-fixed-dose-combination-atorvastatin-amlodipine-perindopril-versus-fixed-dose-combination-of-atorvastatin-amlodipine-in-patients-with-hypertension-and-dyslipidemia/ 2017-10-11T10:10:56+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/safety-and-efficacy-of-fixed-dose-combination-of-indapamide-sr-amlodipine-in-single-pill-versus-free-dual-therapy-at-the-same-dose-over-12-week-of-treatment-with-conditional-titration-based-on-the/ 2017-10-11T10:11:01+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/safety-and-efficacy-of-fixed-dose-combination-of-indapamide-sr-1-5-mg-amlodipine-versus-valsartan-amlodipine-over-12-week-of-treatment-with-conditional-titration-based-on-the-blood-pressure-contro/ 2017-10-11T10:11:07+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-factorial-randomised-trial-of-blood-pressure-lowering-with-a-fixed-low-dose-perindopril-indapamide-combination-and-intensive-glucose-control-with-a-modified-release-gliclazide-based-regimen-for-the/ 2017-10-11T10:11:12+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-of-perindopril-indapamide-combination-on-coronary-pet-scan-parameters-a-6-month-open-non-controlled-study-in-hypertensive-patients/ 2017-10-11T10:11:18+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/clinical-non-inferiority-study-between-daflon-1000-mg-one-oral-suspension-in-a-sachet-per-day-and-daflon-500-mg-2-tablets-daily-after-eight-weeks-of-treatment-in-patients-suffering-from-symptomatic/ 2017-10-11T10:11:23+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/clinical-acceptability-study-of-micronized-purified-flavonoid-fraction-1000-mg-one-tablet-per-day-compared-to-micronized-purified-flavonoid-fraction-500-mg-two-tablets-daily-after-8-weeks-of-treatme/ 2017-10-11T10:11:28+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/clinical-acceptability-study-of-micronized-purified-flavonoid-fraction-1000-mg-tablets-and-micronized-purified-flavonoid-fraction-500-mg-tablets-after-7-days-of-treatment-followed-by-a-follow-up-perio/ 2017-10-11T10:11:33+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/long-term-double-blind-comparison-of-gliclazide-mr-30-to-120-mg-daily-per-os-and-rosiglitazone-4-to-8-mg-daily-per-os-given-in-combination-with-metformin-in-type-2-diabetic-patients-a-2-year-inter/ 2017-10-11T10:11:37+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-gliclazide-mr-30-to-120-mg-per-day-associated-or-not-to-metformine-or-to-an-a-glucosidase-inhibitor-during-the-fast-of-the-ramadan-in-type-2-diabetic-patients-a-5-to-8-months/ 2017-10-11T10:11:42+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/perindopril-amlodipine-regimen-versus-at1-receptor-blocker-thiazide-a-comparison-of-blood-pressure-lowering-efficacy-and-safety-a-randomised-double-blind-9-month-study-of-the-efficacy-and-safety/ 2017-10-11T10:11:46+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-the-fixed-oral-perindopril-arginine-5mg-amlodipine-5mg-combination-compared-with-amlodipine-5mg-alone-in-patients-not-adequately-controlled-with-amlodipine-5mg-monotherapy-a-ra/ 2017-10-11T10:11:50+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-the-fixed-oral-perindopril-arginine-5-mg-amlopidine-5-mg-combination-compared-with-perindopril-tert-butylamine-4-mg-alone-in-patients-not-adequately-controlled-with-perindopril/ 2017-10-11T10:11:55+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/perindopril-arginine-amlodipine-versus-valsartan-amlodipine-antihypertensive-strategies-efficacy-and-safety-in-mild-to-moderate-hypertensive-patients-a-randomised-double-blind-6-month-study-followed/ 2017-10-11T10:11:59+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-on-systolic-and-diastolic-blood-pressure-decrease-and-safety-of-once-a-day-oral-5-mg-perindopril-arginine-salt-titrated-to-10-mg-a-12-week-2-arm-randomised-double-blind-study-versus-onc/ 2017-10-11T10:12:03+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-clinical-efficacy-and-safety-of-perindopril-indapamide-amlodipine-fixed-dose-combination-in-single-pill-versus-free-dual-therapy-at-the-same-dose-as-the-single-pill-combination-i/ 2017-10-11T10:12:09+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-fixed-dose-combination-perindopril-5-mg-indapamide-1-25-mg-amlodipine-5-mg-versus-perindopril-5-mg-indapamide-1-25-mg-single-pill-in-patients-with-uncontrolled-essential-h/ 2017-10-11T10:12:14+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/the-efficacy-and-safety-of-trimetazidine-in-patients-with-angina-pectoris-having-been-treated-by-percutaneous-coronary-intervention-atpci-study-an-international-multicentre-randomised-double-blind/ 2017-10-11T10:12:19+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/clinical-acceptability-of-trimetazidine-80-mg-once-daily-compared-to-trimetazidine-35-mg-twice-daily-in-patients-with-chronic-stable-angina-pectoris-a-multicentre-randomised-double-blind-study/ 2017-10-11T10:12:23+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/the-efficacy-and-safety-of-a-daily-oral-administration-of-s06911-strontium-ranelate-2g-vitamin-d3-1000-iu-fixed-combination-on-vitamin-d-insufficiency-in-the-treatment-of-osteoporotic-postmenopausal/ 2017-10-11T10:12:28+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/the-efficacy-and-safety-of-a-daily-oral-administration-of-s06911-strontium-ranelate-2g-vitamin-d3-1000-iu-fixed-combination-on-vitamin-d-deficiency-in-the-treatment-of-osteoporotic-postmenopausal-wo/ 2017-10-11T10:12:34+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-perindopril-on-mortality-morbidity-in-patients-with-stable-coronary-artery-disease-without-clinical-heart-failure-a-double-blind-multicentre-randomised-trial/ 2017-10-11T10:12:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/soti-and-tropos-phase-iii-studies-open-label-extension-the-long-term-efficacy-and-long-term-safety-assessment-of-a-five-year-oral-administration-of-strontium-ranelate-in-osteoporotic-postmenopausal-w/ 2017-10-11T10:12:42+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/the-efficacy-and-safety-of-2g-strontium-ranelate-in-the-treatment-of-osteoporosis-in-men-a-prospective-multicentre-international-double-blind-placebo-controlled-study-with-a-treatment-duration-of/ 2017-10-11T10:12:47+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/the-efficacy-and-safety-of-two-doses-of-strontium-ranelate-1g-and-2g-per-day-versus-placebo-administered-orally-for-3-years-in-the-treatment-of-knee-osteoarthritis-a-prospective-multicentre-intern/ 2017-10-11T10:12:52+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-double-blind-multicentric-multinational-randomised-study-to-assess-the-effects-of-one-year-administration-of-2-g-per-day-of-strontium-ranelate-versus-marketed-bisphosphonates-in-women-with-postmen/ 2017-10-11T10:12:56+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/the-efficacy-and-safety-of-two-doses-of-strontium-ranelate-versus-placebo-administered-orally-for-3-years-in-the-treatment-of-knee-osteoarthritis-a-prospective-multicentre-international-double-blin/ 2017-10-11T10:13:00+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-double-blind-multicenter-international-randomised-study-to-assess-the-effects-of-6-months-or-12-months-administration-of-2g-per-day-of-strontium-ranelate-versus-alendronate-70mg-per-week-on-bone-r/ 2017-10-11T10:13:05+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/long-term-effects-of-strontium-ranelate-on-knee-osteoarthritis-symptoms-a-2-year-prospective-randomised-placebo-controlled-study/ 2017-10-11T10:13:09+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-double-blind-multicentric-multinational-randomised-study-to-assess-the-effects-of-two-years-administration-of-2-g-per-day-of-strontium-ranelate-versus-alendronate-70-mg-per-week-in-women-with-post/ 2017-10-11T10:13:14+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/the-efficacy-and-safety-of-2g-strontium-ranelate-in-the-treatment-of-male-osteoporosis-a-prospective-multicentre-international-double-blind-placebo-controlled-study-with-a-treatment-duration-of-2/ 2017-10-11T10:13:20+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-multicenter-prospective-randomized-double-blind-placebo-controlled-international-study-to-assess-the-effects-of-2g-per-day-of-strontium-ranelate-versus-placebo-on-the-time-to-fracture-healing-i/ 2017-10-11T10:13:25+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effect-of-strontium-ranelate-2g-per-day-in-the-management-of-long-bone-fractures-with-delayed-union-or-non-union-an-international-open-label-study/ 2017-10-11T10:13:29+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-prospective-controlled-double-blind-international-study-to-assess-the-effects-of-strontium-ranelate-vs-placebo-on-the-reduction-of-periprosthetic-bone-loss-in-patients-with-total-hip-arthroplast/ 2017-10-11T10:13:34+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-24-months-prospective-randomized-double-blind-study-to-assess-the-effect-of-daily-oral-administration-of-2-g-of-strontium-ranelate-versus-placebo-on-bone-mineral-density-in-postmenopausal-osteopo/ 2017-10-11T10:13:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/knee-joint-replacement-over-5-years-in-patients-with-knee-osteoarthritis-a-long-term-follow-up-study-in-patients-of-the-cl3-12911-018-study/ 2017-10-11T10:13:43+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-anti-anginal-efficacy-and-safety-of-ivabradine-used-in-combination-with-an-anti-anginal-monotherapy-in-patients-with-stable-effort-angina-pectoris-a-6-week-randomised-double-blind/ 2017-10-11T10:14:05+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/long-term-3-years-ophthalmic-safety-and-cardiac-efficacy-and-safety-of-ivabradine-administered-orally-at-the-therapeutic-doses-2-5-5-7-5-mg-b-i-d-on-top-of-anti-anginal-background-therapy-to-pat/ 2017-10-11T10:14:09+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-anti-anginal-efficacy-and-safety-of-oral-administration-of-ivabradine-compared-to-placebo-on-top-of-a-background-therapy-with-a-calcium-antagonist-amlodipine-or-nifedipine-in-patie/ 2017-10-11T10:14:14+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-a-10-or-15-mg-single-intravenous-bolus-of-ivabradine-versus-placebo-on-heart-rate-control-during-a-multislice-computed-tomography-coronary-angiography-for-the-evaluation-of-coronary-artery/ 2017-10-11T10:14:19+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/safety-of-oral-chronic-administration-of-ivabradine-modified-release-formulation-compared-to-ivabradine-immediate-release-formulation-in-patients-with-stable-coronary-artery-disease-a-6-to-12-month/ 2017-10-11T10:14:30+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/safety-of-oral-chronic-administration-of-ivabradine-modified-release-formulation-compared-to-ivabradine-immediate-release-formulation-in-patients-with-chronic-heart-failure-and-left-ventricular-systol/ 2017-10-11T10:14:34+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-ivabradine-on-plaque-burden-morphology-and-composition-in-patients-with-clinically-indicated-coronary-angiography-a-randomised-double-blind-placebo-controlled-international-multicentre-st/ 2017-10-11T10:14:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/prevention-of-cerebrovascular-and-cardiovascular-events-of-ischaemic-origin-with-terutroban-in-patients-with-a-history-of-ischaemic-stroke-or-transient-ischaemic-attack-the-perform-study-an-internat/ 2017-10-11T10:14:43+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-study-to-determine-the-maintenance-of-efficacy-of-agomelatine-25-mg-to-50-mg-to-prevent-relapse-in-out-patients-with-major-depressive-disorder-a-8-to-10-weeks-open-period-treatment-with-agomelati/ 2017-10-11T10:14:48+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-25-mg-day-with-potential-adjustment-to-50-mg-given-orally-for-8-weeks-in-out-patients-with-severe-major-depressive-disorder-a-randomised-double-blind-parallel-gr/ 2017-10-11T10:14:54+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-of-agomelatine-25-mg-day-with-potential-adjustment-to-50-mg-given-orally-on-rest-activity-circadian-rhythms-in-outpatients-with-major-depressive-disorder-a-randomized-double-blind-interna/ 2017-10-11T10:14:58+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-25-mg-day-with-potential-adjustment-at-50-mg-day-given-orally-compared-to-placebo-in-addition-to-a-mood-stabilizer-in-bipolar-i-patients-with-a-current-major-depr/ 2017-10-11T10:15:04+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-of-agomelatine-25-to-50-mg-day-given-orally-on-quality-of-remission-in-elderly-depressed-patients-after-a-12-week-treatment-period-a-randomised-double-blind-flexible-dose-international-m/ 2017-10-11T10:15:09+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/long-term-efficacy-and-safety-of-agomelatine-in-non-depressed-out-patients-with-generalized-anxiety-disorder-a-26-week-randomised-double-blind-placebo-controlled-parallel-group-study-following-an-open/ 2017-10-11T10:15:14+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-25-mg-day-with-potential-blinded-adjustment-at-50-mg-day-for-12-weeks-in-non-depressed-out-patients-with-generalized-anxiety-disorder-a-12-week-randomised-double/ 2017-10-11T10:15:23+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-with-flexible-dose-25-mg-day-with-potential-adjustment-at-50-mg-given-orally-for-8-weeks-in-out-patients-with-major-depressive-disorder/ 2017-10-11T10:15:27+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-agomelatine-25-to-50-mg-day-on-sleep-eeg-parameters-compared-to-escitalopram-in-patients-with-major-depressive-disorder-a-6-week-randomised-double-blind-parallel-groups-study-versus-com/ 2017-10-11T10:15:32+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-agomelatine-versus-escitalopram-on-emotional-experiences-in-outpatients-suffering-from-major-depressive-disorder-an-exploratory-randomised-double-blind-international-multicentre-study/ 2017-10-11T10:15:37+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-efficacy-and-clinical-benefit-of-agomelatine-25-to-50-mg-day-over-a-6-month-treatment-period-in-patients-with-major-depressive-disorder-a-randomised-double-blind-international-multic/ 2017-10-11T10:15:43+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-of-agomelatine-25-to-50-mg-day-given-orally-on-improvement-of-subjective-sleep-in-patients-with-major-depressive-disorder-a-randomised-double-blind-flexible-dose-international-multicentr/ 2017-10-11T10:15:48+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-3-dose-regimens-of-agomelatine-10-25-25-50-mg-versus-placebo-given-once-a-day-for-6-weeks-in-out-patients-suffering-from-moderate-to-severe-major-depressive-disorder-a-6-we/ 2017-10-11T10:15:52+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-oral-administration-25-to-50-mg-day-in-elderly-patients-suffering-from-major-depressive-disorder-a-8-week-randomised-double-blind-flexible-dose-parallel-group/ 2017-10-11T10:15:57+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-25-mg-day-with-potential-blinded-adjustment-to-50-mg-day-for-12-weeks-in-non-depressed-out-patients-with-generalized-anxiety-disorder-a-12-week-randomised-double/ 2017-10-11T10:16:02+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/initiation-of-agomelatine-after-antidepressant-treatment-by-ssri-or-snri-in-outpatients-suffering-major-depressive-disorder-a-3-week-randomised-double-then-single-blind-controlled-parallel-groups/ 2017-10-11T10:16:07+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-with-flexible-dose-25-mg-day-with-blinded-potential-adjustment-at-50-mg-given-orally-for-8-weeks-in-indian-outpatients-with-major-depressive-disorder-a-randomised/ 2017-10-11T10:16:12+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-2-doses-of-agomelatine-10mg-25mg-given-orally-in-children-from-7-to-less-than-12-years-and-adolescents-from-12-to-less-than-18-years-with-moderate-to-severe-major-depress/ 2017-10-11T10:16:15+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-25-50-mg-day-for-12-weeks-in-patients-with-generalized-anxiety-disorder-a-randomised-controlled-trial/ 2017-10-11T10:16:19+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effects-of-agomelatine-25-to-50-mg-day-on-circadian-rhythms-in-patients-with-major-depressive-disorder-an-exploratory-6-week-open-flexible-dose-international-multicentre-non-comparative-study/ 2017-10-11T10:16:23+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/early-effect-of-agomelatine-on-general-interest-in-outpatients-with-major-depressive-disorder-a-12-week-randomized-double-blind-multicentre-study-with-parallel-groups-agomelatine-25mg-day-given/ 2017-10-11T10:16:28+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-2-doses-of-agomelatine-10-mg-day-or-25-mg-day-versus-placebo-given-orally-for-12-weeks-in-non-depressed-out-patients-with-generalized-anxiety-disorder-a-12-week-randomised-d/ 2017-10-11T10:16:33+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-agomelatine-25mg-day-with-blinded-potential-adjustment-to-50mg-day-versus-escitalopram-10mg-day-with-blinded-potential-adjustment-to-20mg-day-given-orally-for-12-weeks-in-no/ 2017-10-11T10:16:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-effect-of-the-oral-administration-of-perindopril-orodispersible-at-a-dose-of-0-150-mg-kg-day-on-the-muscular-and-myocardial-function-in-early-stage-duchenne-muscular-dystrophy-doubl/ 2017-10-11T10:16:54+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/response-to-valdoxan-and-restoration-of-social-rhythms-in-major-depressive-disorder-valdoxan-d-rhythm-study-interventional-phase-iv-multicentre-clinical-study/ 2017-10-11T10:17:03+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/clinical-efficacy-of-valdoxan-in-everyday-practice-conditions-efficiency-in-depressed-patients-on-a-treatment-naive-or-switch-basis-phase-iv-multicentre-open-interventional-clinical-study-vald/ 2017-10-11T10:17:11+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/clinical-long-term-effects-of-valdoxan-25-or-50-mg-in-depressed-patients-clinical-national-interventional-phase-iv-multicentre-open-study-valdoxan-d-extension-study/ 2017-10-11T10:17:19+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/patient-preference-and-satisfaction-for-perindopril-orodispersible-vs-conventional-tablets-in-daily-clinical-practice-preference/ 2017-10-11T10:17:26+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/detralex-versus-placebo-in-the-treatment-of-acute-hemorrhoids-in-patients-with-acute-hemorrhoidal-attack-one-week-double-blind-randomized-placebo-controlled-multicentre-study-hemodex-study/ 2017-10-11T10:17:34+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-of-detralex-in-edema-treatment-an-open-6-month-multicentre-study-edet-study/ 2017-10-11T10:17:41+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/protelos-2g-in-the-osteoporosis-treatment-the-tolerability-and-efficacy-profile-prostep/ 2017-10-11T10:17:49+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-valdoxan-given-orally-once-a-day-for-24-weeks-in-patients-with-major-depressive-disorder-open-national-multicentric-clinical-trial-for-the-evaluation-of-the-antidepress/ 2017-10-11T10:17:55+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/study-of-the-effect-of-trimetazidine-mr-35-mg-2-tabs-day-on-the-emergence-of-choroidal-neovascularisation-in-age-related-macular-degeneration-a-multicentre-randomised-double-blind-placebo-contro/ 2017-10-11T10:18:06+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-study-to-assess-the-release-profiles-from-fixed-combination-tablets-gliclazide-mr-metformin/ 2017-10-11T10:18:12+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/effect-of-3-doses-20-40-and-60-mg-of-a-sublingual-formulation-of-piribedil-s-90049-in-combination-with-levodopa-on-end-of-dose-fluctuations-in-advanced-parkinsons-disease-patients-after/ 2017-10-11T10:18:18+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/assessment-of-the-acceptability-of-a-sublingual-formulation-of-piribedil-s90049-10-to-30-mg-on-request-maximum-5-times-a-day-on-the-top-of-l-dopa-and-a-dopamine-agonist-in-advanced-parkinson-dise/ 2017-10-11T10:18:26+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/prospective-multicenter-open-label-phase-iv-trial-of-trifluridine-tipiracil-to-evaluate-the-health-related-quality-of-life-in-patients-with-metastatic-colorectal-cancer/ 2017-10-11T10:18:33+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/ines-phase-ib-dose-allocation-study-of-oral-administration-of-lucitanib-given-in-combination-with-fulvestrant-in-patients-with-oestrogen-receptor-positive-and-fgfr1-amplified-or-non-amplified/ 2017-11-09T10:25:39+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-ii-study-of-s49076-a-multi-target-inhibitor-of-c-met-axl-fgfr-in-combination-with-bevacizumab-in-patients-with-recurrent-glioblastoma-multiforme/ 2017-12-19T09:37:56+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/clinical-non-inferiority-study-between-micronized-purified-flavonoid-fraction-1000-mg-one-chewable-tablet-per-day-and-micronized-purified-flavonoid-fraction-500-mg-2-tablets-daily-after-eight-wee/ 2018-06-19T06:01:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-clinical-study-to-test-the-safety-and-the-efficacy-of-a-single-pill-combination-of-2-antihypertensive-and-1-lipid-lowering-drug-in-patients-already-well-treated-with-the-concomitant-administration-o/ 2018-06-19T06:18:18+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-of-ivabradine-in-combination-with-beta-blockers-vs-up-titration-of-beta-blockers-in-daily-practice/ 2018-06-19T06:27:36+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/efficacy-and-safety-of-3-doses-of-s201086-glpg1972-administered-orally-once-daily-in-patients-with-knee-osteoarthritis-a-52-week-international-multi-regional-multi-center-randomized-double-blind/ 2018-06-21T15:22:05+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-phase-i-ii-open-label-non-randomized-study-to-evaluate-safety-tolerability-pharmacokinetics-and-clinical-activity-of-s64315-in-patients-with-locally-advanced-or-metastatic-breast-cancer-in-combi/ 2019-10-02T14:55:43+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/phase-i-ii-open-label-dose-escalation-part-phase-i-followed-by-noncomparative-expansion-part-phase-ii-multi-centre-study-evaluating-safety-pharmacokinetics-and-efficacy-of-s65487-a-bcl2-in-2/ 2021-02-04T12:57:53+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-multicentre-randomized-double-blind-placebo-controlled-dose-finding-study-of-s62798-in-patients-with-intermediate-high-risk-acute-pulmonary-embolism-on-heparin/ 2021-03-09T13:22:26+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/evaluation-of-the-clinical-efficacy-and-safety-of-perindopril-10-mg-indapamide-2-5-mg-amlodipine-5-or-10-mg-bisoprolol-5-mg-in-single-pill-combination-after-8-weeks-of-treatment-versus-the-free-combin/ 2022-02-08T17:08:22+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/study-assessing-the-glucose-lowering-efficacy-and-safety-of-luseogliflozin-on-top-of-metformin-in-caucasian-patients-with-type-2-diabetes-mellitus/ 2022-09-22T15:20:27+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/exploratory-bioavailability-of-two-formulations-of-gliclazide-mr-tablets-120-mg-i-r-i-s-in-healthy-volunteers-under-fed-and-fasting-conditions/ 2024-08-07T06:30:51+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/comparative-pharmacokinetic-study-of-three-prolonged-release-formulations-and-one-immediate-release-formulation-of-s221237-after-single-oral-administration-in-fed-conditions-an-open-label-randomized/ 2024-11-15T16:37:41+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/exploratory-bioavailability-of-three-formulations-of-gliclazide-mr-tablets-120-mg-i-r-i-s-in-healthy-volunteers-under-fed-conditions-high-fat-high-calorie-meal-and-standard-meal/ 2025-01-30T11:06:54+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/etude-de-lefficacite-et-de-la-securite-du-s-95005-tas-102-chez-des-patients-atteints-de-cancer-colorectal-metastatique-ayant-echoue-aux-chimiotherapies-standard/ 2025-09-04T09:58:55+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/efficacite-et-securite-du-s95011-chez-les-patients-atteints-du-syndrome-de-sjogren-primaire/ 2025-09-04T14:20:44+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/une-etude-comparant-les-niveaux-sanguins-des-deux-formulations-de-pegaspargase-s95014-liquide-vs-lyophilise-dans-le-traitement-des-patients-pediatriques-atteints-de-leucemie-lymphoblastique-aigue/ 2025-09-04T14:54:38+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-multi-center-open-label-single-arm-phase-2-3-trial-evaluating-the-safety-and-pharmacokinetics-of-calaspargase-pegol-for-treatment-of-adults-aged-22-to-65-years-with-newly-diagnosed-philadelphi/ 2025-09-16T07:27:10+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/calaspargase-pegol-chez-les-adultes-atteints-de-lla/ 2025-09-16T08:21:25+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/une-etude-de-phase-2-sur-livosidenib-chez-des-sujets-japonais-precedemment-traites-atteints-de-cholangiocarcinome-non-resecable-ou-metastatique-avec-une-mutation-de-lidh1/ 2025-09-16T09:19:05+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/une-etude-sur-le-trifluridine-tipiracil-egalement-connu-sous-le-nom-de-s-95005-ou-tas-102-chez-des-patients-atteints-dun-cancer-colorectal-pretraite-qui-sest-propage-metastatique-preconnect/ 2025-09-18T09:49:19+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/une-etude-clinique-de-shp674-pegaspargase-chez-des-participants-atteints-de-leucemie-aigue-lymphoblastique-nouvellement-diagnostiquee-et-non-traitee/ 2025-09-19T14:30:04+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/ivosidenib-en-combinaison-avec-durvalumab-et-gemcitabine-cisplatine-en-tant-que-traitement-de-premiere-ligne-chez-des-participants-atteints-de-cholangiocarcinome-localement-avance-ou-metastatique-avec/ 2025-09-23T13:17:31+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/vorasidenib-en-combinaison-avec-temozolomide-tmz-dans-le-gliome-mutant-idh/ 2025-09-23T13:29:22+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/monotherapie-avec-ivosidenib-ivo-et-monotherapie-avec-azacitidine-aza-chez-des-patients-atteints-de-syndromes-myelodysplasiques-smd-naifs-dagents-hypomethylants-hma-avec-une-mutation-idh1-p/ 2025-09-23T13:34:44+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/une-etude-pour-evaluer-la-securite-demploi-et-lactivite-du-s095029-dans-le-cadre-dune-therapie-combinee-chez-des-patients-atteints-de-cancers-avances-de-la-jonction-gastro-oesophagienne-g/ 2025-09-23T13:43:40+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/etude-de-la-combinaison-vorasidenib-et-pembrolizumab-dans-le-gliome-mutant-idh-1-recurrent-ou-progressif/ 2025-09-23T13:53:53+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/etude-de-lag-120-administre-par-voie-orale-chez-des-sujets-atteints-de-malignites-hematologiques-avancees-avec-une-mutation-idh1/ 2025-09-30T09:07:22+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/une-etude-pour-evaluer-le-s227928-en-tant-quagent-unique-et-en-combinaison-avec-le-venetoclax-chez-des-patients-atteints-de-lma-r-r-smd-lma-ou-lmmc/ 2025-09-30T09:13:45+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/s095035-en-tant-quagent-unique-et-en-combinaison-chez-des-participants-adultes-atteints-de-tumeurs-solides-avancees-ou-metastatiques-avec-deletion-de-mtap/ 2025-09-30T09:49:51+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/etude-plateforme-de-phase-1b-2-sur-des-combinaisons-dimmunotherapies-selectionnees-chez-des-participants-atteints-de-cancer-du-poumon-non-a-petites-cellules-cpnpc-avance/ 2025-09-30T09:54:12+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/etude-de-vorasidenib-ag-881-chez-des-participants-atteints-de-gliome-de-grade-2-residuel-ou-recurrent-avec-une-mutation-idh1-ou-idh2-indigo/ 2025-10-02T11:19:16+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/etude-de-phase-3-sur-le-vorasidenib-s095032-ag-881-chez-des-participants-asiatiques-atteints-de-gliome-de-grade-2-residuel-ou-recurrent-avec-une-mutation-idh1-ou-idh2/ 2025-10-03T13:29:44+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/fr/trial/ivosidenib-chez-des-participants-atteints-de-chondrosarcome-conventionnel-localement-avance-ou-metastatique-non-traite-ou-ayant-recu-un-traitement-systemique-prealable-chonquer/ 2025-11-25T09:00:20+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png https://ctrials.licorn-servier.dev/trial/a-study-to-evaluate-the-efficacy-and-safety-of-gliclazide-mr-in-patients-with-type-2-diabetes-inadequately-controlled-with-dapagliflozin-with-or-without-metformin/ 2025-11-25T10:16:39+00:00 https://ctrials.licorn-servier.dev/wp-content/uploads/2025/01/cover-6.png